Publications by authors named "Farshid Dayyani"

46Publications

Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients.

J Gastrointest Oncol 2020 Oct;11(5):952-963

Department of General Surgery, University of California in Los Angeles, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo-20-212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657833PMC
October 2020

Predictors of outcomes in patients with gastric cancer treated with contemporary multimodality strategies-a single institution experience.

J Gastrointest Oncol 2020 Apr;11(2):411-420

Department of Medicine, Division of Hematology and Oncology, University of California in Irvine, Irvine, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2019.01.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212096PMC
April 2020

Gene mutations distinguishing gastric from colorectal and esophageal adenocarcinomas.

J Gastrointest Oncol 2020 Feb;11(1):45-54

Department of Medicine, Division of Hematology and Oncology, University of California in Irvine, Irvine, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2019.12.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052769PMC
February 2020

Management of Urothelial Bladder Cancer in Clinical Practice: Real-World Answers to Difficult Questions.

J Oncol Pract 2019 08;15(8):421-428

1University of California Irvine, Orange, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.19.00215DOI Listing
August 2019

Analysis of Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies.

JCO Precis Oncol 2018 13;2018. Epub 2018 Jul 13.

University of California, San Diego, Moores Cancer Center, La Jolla.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106866PMC
http://dx.doi.org/10.1200/PO.17.00235DOI Listing
July 2018

Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis.

Br J Cancer 2017 Apr 9;116(8):1037-1045. Epub 2017 Mar 9.

Division of Hematology/Oncology, Department of Medicine, University of California Irvine, 101 The City Drive South, Orange, CA 92868, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.45DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396105PMC
April 2017

Clinically Meaningful Use of Blood Tumor Markers in Oncology.

Biomed Res Int 2016 30;2016:9795269. Epub 2016 Nov 30.

Roche Diagnostics International, Rotkreuz, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/9795269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155072PMC
January 2017

Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis.

Int J Gynecol Cancer 2016 11;26(9):1586-1593

*Roche Diagnostics International, Rotkreuz, Switzerland; †QuoData, Freising; ‡QuoData, Dresden; and §Roche Diagnostics GmbH, Penzberg, Germany; ∥Roche Professional Diagnostics, Indianapolis, IN; and ¶Division of Surgery, Banner MD Anderson Cancer Center, Gilbert, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000804DOI Listing
November 2016

The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study.

BMC Cancer 2016 09 6;16:721. Epub 2016 Sep 6.

Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2723-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013640PMC
September 2016

TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemia.

Leuk Res 2016 09 21;48:46-56. Epub 2016 Jul 21.

Department of Pediatrics, Divisions of Pediatric Hematology/Oncology and Medical Genetics, Massachusetts General Hospital, Boston, MA 02114, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266616PMC
September 2016

In Response to "Serum Tumor Marker Use in Patients With Advanced Solid Tumors".

J Oncol Pract 2016 Mar 2;12(3):273-4. Epub 2016 Feb 2.

University of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.009241DOI Listing
March 2016

Management of advanced primary urethral carcinomas.

BJU Int 2014 Jul 22;114(1):25-31. Epub 2014 May 22.

Division of Hematology and Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12630DOI Listing
July 2014

Ligand-independent activation of MET through IGF-1/IGF-1R signaling.

Int J Cancer 2013 Oct 17;133(7):1536-46. Epub 2013 Apr 17.

Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713179PMC
October 2013

Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.

Clin Cancer Res 2013 Feb 18;19(3):657-67. Epub 2012 Dec 18.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, and Graduate School of Biomedical Sciences, University of Texas, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563727PMC
February 2013

Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists.

Urol Oncol 2013 Oct 24;31(7):1171-7. Epub 2012 Apr 24.

Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-3721, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S107814391200041
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2012.01.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131852PMC
October 2013

Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint.

Eur J Immunol 2012 Apr;42(4):957-74

Comprehensive Pneumology Center, Helmholtz Zentrum München, Ludwig-Maximilians University and Asklepios Fachklinik Gauting, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201141907DOI Listing
April 2012

The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials.

Expert Opin Investig Drugs 2011 Dec 28;20(12):1677-84. Epub 2011 Oct 28.

University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, Clinical Research Building (T7.3891), 1515 Holcombe Blvd, Unit 0018-4, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1517/13543784.2011.6
Publisher Site
http://dx.doi.org/10.1517/13543784.2011.631523DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020016PMC
December 2011

Novel therapies for metastatic castrate-resistant prostate cancer.

J Natl Cancer Inst 2011 Nov 13;103(22):1665-75. Epub 2011 Sep 13.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djr362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176261PMC
November 2011

Steps in prostate cancer progression that lead to bone metastasis.

Int J Cancer 2011 Jun 28;128(11):2545-61. Epub 2011 Mar 28.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.26024
Publisher Site
http://dx.doi.org/10.1002/ijc.26024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082284PMC
June 2011

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

Head Neck Oncol 2010 Jun 29;2:15. Epub 2010 Jun 29.

Department of Thoracic/Head & Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://headandneckoncology.biomedcentral.com/articles/10.118
Publisher Site
http://dx.doi.org/10.1186/1758-3284-2-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908081PMC
June 2010

HIV-associated multicentric Castleman's disease.

Am J Hematol 2008 Jun;83(6):498-503

Department of Medical Oncology, Imperial College School of Science, Technology and Medicine, The Hammersmith Hospitals NHS Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21137DOI Listing
June 2008

Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.

Blood 2008 Apr 7;111(8):4338-47. Epub 2008 Feb 7.

Department of Pediatrics, Division of Pediatric Hematology/Oncology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-07-103291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2288729PMC
April 2008

Multicentric Castleman's disease masquerading as HIV-related lymphoma.

Am J Med Sci 2007 Oct;334(4):317-9

Department of Medicine, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAJ.0b013e3180a5e96bDOI Listing
October 2007

The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase.

Blood 2004 Sep 25;104(6):1825-32. Epub 2004 May 25.

Laboratory for Molecular Haematology, Department of Haematology and Oncology, Klinikum der Universität München, Medizinische Klinik-Innenstadt, Ziemssenstrasse 1, 80336 Munich, Germany.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2003-12-42
Publisher Site
http://dx.doi.org/10.1182/blood-2003-12-4218DOI Listing
September 2004

Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphoma.

J Leukoc Biol 2004 Feb 23;75(2):207-13. Epub 2003 Oct 23.

Department of Hematology and Oncology, Medical Clinic Campus Innenstadt, University of Munich, Ziemmssenstrasse 1, 80336 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0803386DOI Listing
February 2004

Treosulfan is an effective inducer of cell death in myeloma cell lines and primary myeloma cells from patients.

Br J Haematol 2003 Sep;122(6):892-9

Klinikum der Universität München, Medizinische Klinik - Innenstadt, Department of Hematology/Oncology, Laboratory of Molecular Hematology and Oncology, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04525.xDOI Listing
September 2003

Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytes.

J Leukoc Biol 2003 Jul;74(1):33-9

Institute for Immunology and. Medizinische Poliklinik, University of Muenchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.1202612DOI Listing
July 2003